Impact of sauerkraut consumption on metabolic control, inflammatory status and host-microbiome-interactions - Trial DRKS00027007
Access comprehensive clinical trial information for DRKS00027007 through Pure Global AI's free database. This phase not specified trial is sponsored by Universitätsklinikum FreiburgProf. Dr. Dr. Karin MichelsElsässer Straße 279110 FreiburgGermany and is currently Recruitment Completed. The study focuses on None ;Healthy volunteers.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Deutsches Register Klinischer Studien data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Interventional
Sponsor & Location
Universitätsklinikum FreiburgProf. Dr. Dr. Karin MichelsElsässer Straße 279110 FreiburgGermany
Universitätklinikum Freiburg Institut für Prävention und TumorepidemiologieElsässer Straße 279110 FreiburgGermany
Timeline & Enrollment
N/A
N/A
N/A
Summary
The gut microbiome has been associated with a number of diseases including obesity and holds great potential for the treatment or prevention of various illnesses. Fresh fermented vegetables, such as sauerkraut, contain a large number of lactic acid bacteria that may have beneficial effects on host metabolism. We therefore hypothesize that daily consumption of sauerkraut with live lactic acid bacteria improves metabolic and inflammatory status of healthy and overweight study participants via modulation of the gut microbiome. Furthermore, we expect a similar effect from consumption of pasteurized sauerkraut with heat-killed bacteria compliant with the postbiotic concept (a postbiotic is a “preparation of inanimate microorganisms and/or their components that confers a health benefit on the host”).
ICD-10 Classifications
Data Source
Deutsches Register Klinischer Studien
DRKS00027007
Non-Device Trial